TAFASITAMAB-CXIX for Product used for unknown indication: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 115 adverse event reports in the FDA FAERS database where TAFASITAMAB-CXIX was used for Product used for unknown indication.
Most Reported Side Effects for TAFASITAMAB-CXIX
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Disease progression | 218 | 29.6% | 41 | 8 |
| Lymphoma | 158 | 21.5% | 3 | 7 |
| Off label use | 126 | 17.1% | 7 | 20 |
| Death | 53 | 7.2% | 53 | 3 |
| Drug ineffective | 39 | 5.3% | 19 | 5 |
| Blood lactate dehydrogenase increased | 34 | 4.6% | 14 | 0 |
| Diffuse large b-cell lymphoma | 32 | 4.4% | 13 | 4 |
| Malignant neoplasm progression | 30 | 4.1% | 5 | 3 |
| Neutropenia | 30 | 4.1% | 5 | 7 |
| Polyneuropathy | 29 | 3.9% | 0 | 8 |
| Covid-19 | 28 | 3.8% | 9 | 17 |
| Cytopenia | 25 | 3.4% | 0 | 1 |
| Ill-defined disorder | 21 | 2.9% | 0 | 1 |
| Product use issue | 21 | 2.9% | 2 | 1 |
| Neoplasm progression | 20 | 2.7% | 7 | 0 |
Other Indications for TAFASITAMAB-CXIX
Diffuse large b-cell lymphoma (429)
Follicular lymphoma (58)
Diffuse large b-cell lymphoma refractory (31)
Lymphoma transformation (23)
Lymphoma (13)
Marginal zone lymphoma (13)
Diffuse large b-cell lymphoma recurrent (8)
Non-hodgkin's lymphoma (7)
B-cell lymphoma (5)
Marginal zone lymphoma refractory (5)
Other Drugs Used for Product used for unknown indication
OXYCODONE (129,391)
ADAPALENE (91,681)
APIXABAN (88,417)
ETANERCEPT (71,866)
SACUBITRIL\VALSARTAN (69,693)
ACETAMINOPHEN (68,427)
AVOBENZONE\OCTISALATE\OCTOCRYLENE (65,206)
ADALIMUMAB (63,549)
EVOLOCUMAB (60,696)
MORPHINE (59,440)